Jan 14 2022 Reviewed by Danielle Ellis, B.Sc. Bedford, UK | 13th January 2022 – MIP Diagnostics Ltd. has today announced that its synthetic SARS-CoV-2 antibody (COVID-19 nanoMIPTM) can detect the Omicron variant as well as previously proven Alpha, Beta, Delta, and Gamma variants of the COVID-19 virus. MIP Diagnostics, the leading manufacturer of molecularly imprinted...
FEBRUARY 3RD, 2021 MEDGADGET EDITORS MEDICINE, PUBLIC HEALTH Although a few types of COVID-19 vaccines have begun to be distributed around the world, a unique technology, developed at University of California, San Francisco, may offer an even more direct way to prevent the coronavirus from multiplying within the body. The UCSF team created a synthetic antibody that prevents...
